These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 27349764)
21. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113 [TBL] [Abstract][Full Text] [Related]
22. Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Reboursiere E; Le Bras F; Herbaux C; Gyan E; Clavert A; Morschhauser F; Malak S; Sibon D; Broussais F; Braun T; Fornecker LM; Garidi R; Tricot S; Houot R; Joly B; Abarah W; Choufi B; Pham AD; Gac AC; Fruchart C; Marin E; Safar V; Parcelier A; Maisonneuve H; Bachy E; Cartron G; Jaccard A; Tournilhac O; Rossi C; Schirmer L; Martignoles JA; Gaulard P; Tilly H; Damaj G; Oncotarget; 2016 Dec; 7(51):85573-85583. PubMed ID: 27458168 [TBL] [Abstract][Full Text] [Related]
23. Subcutaneous Panniculitis-Like T-Cell Lymphoma Versus Lupus Erythematosus Panniculitis: Distinction by Means of the Periadipocytic Cell Proliferation Index. Sitthinamsuwan P; Pattanaprichakul P; Treetipsatit J; Pongpruttipan T; Sukpanichnant S; Pincus LB; McCalmont TH Am J Dermatopathol; 2018 Aug; 40(8):567-574. PubMed ID: 29742552 [TBL] [Abstract][Full Text] [Related]
24. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified. Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762 [TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433 [TBL] [Abstract][Full Text] [Related]
26. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study. Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551 [TBL] [Abstract][Full Text] [Related]
27. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network. Federico M; Bellei M; Marcheselli L; Schwartz M; Manni M; Tarantino V; Pileri S; Ko YH; Cabrera ME; Horwitz S; Kim WS; Shustov A; Foss FM; Nagler A; Carson K; Pinter-Brown LC; Montoto S; Spina M; Feldman TA; Lechowicz MJ; Smith SM; Lansigan F; Gabus R; Vose JM; Advani RH; Br J Haematol; 2018 Jun; 181(6):760-769. PubMed ID: 29672827 [TBL] [Abstract][Full Text] [Related]
28. Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis. LeBlanc RE; Lansigan F J Cutan Pathol; 2021 Apr; 48(4):572-577. PubMed ID: 32894575 [TBL] [Abstract][Full Text] [Related]
29. Survival advantage with the addition of radiation therapy to chemotherapy in early stage peripheral T-cell lymphoma, not otherwise specified. Zhang XM; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Zhou LQ; Liu XF; Yu ZH Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1051-6. PubMed ID: 23021436 [TBL] [Abstract][Full Text] [Related]
30. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database. Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725 [TBL] [Abstract][Full Text] [Related]
31. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan. Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741 [TBL] [Abstract][Full Text] [Related]
32. Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival. Davis O; Truong D; Day S; Pandey M; Ibrahimi S; Khawandanah M; Holter-Chakrabarty J; Asch A; Al-Juhaishi T Cancer Med; 2023 Dec; 12(24):21770-21778. PubMed ID: 38073461 [TBL] [Abstract][Full Text] [Related]
34. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma. Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915 [TBL] [Abstract][Full Text] [Related]
35. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides. Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838 [TBL] [Abstract][Full Text] [Related]